SCHEMBL22013479

SCHEMBL22013479

CNCCC(C)(C)OCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20243585 0.86
SCHEMBL12559718 0.81 TSHR (0.35)
SCHEMBL15944115 0.81 ALDH1A1 (0.36)
SCHEMBL26359543 0.81
SCHEMBL17689592 0.80
SCHEMBL20284089 0.80
SCHEMBL12446095 0.79 ALDH1A1 (0.33)
SCHEMBL11915791 0.78 ARG1 (0.30)
SCHEMBL23463261 0.77 ALDH1A1 (0.32)
SCHEMBL22386254 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024102956-A1 KETO-AMIDE-BASED FIBROBLAST ACTIVATION PROTEIN-TARGETED LIGAND LINKED TO AN IMAGING OR THERAPEUTIC AGENT, COMPOSITIONS AND METHODS OF USE PURDUE RESEARCH FOUNDATION (US) 2024-05-16 WO disclosed
US-10662212-B2 Carbohydrate ligands that bind to IGM antibodies against myelin-associated glycoprotein UNIVERSITAT BASEL (CH) 2020-05-26 US disclosed